Pernix Ireland Pain

Pernix Ireland Pain was an Irish pharmaceutical subsidiary within the Pernix group focused on pain-related branded products and associated intellectual property. Publicly available filings describe its principal activities as the development and licensing of pharmaceutical and related products, and legal and product records tie the entity to Zohydro ER and pain-focused assets. The company was originally incorporated in Ireland in 2015 as Pernix Ireland Pain Limited and later re-registered as Pernix Ireland Pain Designated Activity Company. It was part of the broader Pernix Therapeutics group that filed for Chapter 11 bankruptcy in February 2019. The Irish entity itself also appears in the affiliated bankruptcy proceedings and is reported in Irish company databases as dissolved/inactive. As a result, it should be viewed as a former operating IP/holding subsidiary rather than an active standalone biotech company.